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Abstract: Many Australians are intermittently exposed to landscape fire smoke from wildfires or
planned (prescribed) burns. This study aimed to investigate effects of outdoor smoke from planned
burns, wildfires and a coal mine fire by assessing biomarkers of inflammation in an exposed and
predominantly older population. Participants were recruited from three communities in south-
eastern Australia. Concentrations of fine particulate matter (PM2.5) were continuously measured
within these communities, with participants performing a range of health measures during and
without a smoke event. Changes in biomarkers were examined in response to PM2.5 concentrations
from outdoor smoke. Increased levels of FeNO (fractional exhaled nitric oxide) (β = 0.500 [95%CI
0.192 to 0.808] p < 0.001) at a 4 h lag were associated with a 10 µg/m3 increase in PM2.5 levels from
outdoor smoke, with effects also shown for wildfire smoke at 4, 12, 24 and 48-h lag periods and coal
mine fire smoke at a 4 h lag. Total white cell (β = −0.088 [−0.171 to −0.006] p = 0.036) and neutrophil
counts (β = −0.077 [−0.144 to −0.010] p = 0.024) declined in response to a 10 µg/m3 increase in
PM2.5. However, exposure to outdoor smoke resulting from wildfires, planned burns and a coal mine
fire was not found to affect other blood biomarkers.
Keywords: smoke; PM2.5; landscape fire; bushfire; biomarkers; FeNO; neutrophils; white cell count
1. Introduction
With climate change, wildfires in Australia are forecast to increase in frequency and
severity [1–3]. Wildfires present physical risks to individuals and communities from both
direct exposure to intense heat and flames, but also from widespread exposure to smoke [4].
Planned (prescribed) burns are conducted to reduce fire fuel loads in bushland and ar-
eas surrounding communities [5]. These are designed to reduce the risk of catastrophic
wildfires [6,7]. Both wildfires and planned burns are a common occurrence in Australia,
and exposure to smoke from wildfires or planned burns is inevitable for the majority of
Australians [8].
Wild fire and planned burn smoke contains a variety of inorganic and organic com-
pounds, as well as airborne particulates [9]. Particulate matter with a median aerodynamic
diameter smaller than 2.5 micrometres (PM2.5) is a significant component of the smoke [10].
The small size of these fine particles allows them to penetrate deeply into the lungs [11].
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These fine particulates have been linked with chronic health conditions, such as asthma,
chronic obstructive pulmonary disease (COPD), ischaemic heart disease (IHD) and lower
respiratory infections (LRI) [12].
While the acute effects of urban background PM2.5 are well documented for premature
mortality, hospital admissions, emergency presentations and ambulance call-outs [12], the
acute effects of PM2.5 on biomarkers of systemic and airway inflammation are less well
understood, particularly in the context of smoke from wild fires. Exposure to smoke from
wild fire smoke has been associated with an increased risk of out of hospital cardiac arrests
and IHD [13]. Most studies involving the health effects of wild fires focus on discrete
outcomes and events such as mortality and hospital episodes [14–16]. However, there has
been limited evidence of the acute effects of exposure to outdoor smoke on populations.
This study investigated the effect of short-term exposures to wild fire, planned burn, and
coal mine fire smoke on markers of inflammation.
2. Materials and Methods
We performed a short-term panel study of rural Victorian residents during the pre-
scribed burns season and winter period over four consecutive years (Table 1). The detailed
methodology has been published previously [17]. We present here a brief summary of
the methods.
Table 1. Number of assessments conducted per year and exposure type. Note that no clean air assessments were conducted
in 2016. Assessments were carried out on those participants who were tested in Warburton in 2015 when there was
no smoke.
Location and Year Number of Assessments Type of Smoke Number of Assessments Type of Smoke
Warburton 2013 14 Planned burn 10 No smoke
Warburton 2014 44 Wild fire 39 No smoke
Traralgon 2014 42 Coal Mine Fire 29 No smoke
Maffra 2014 21 No smoke 14 No smoke
Warburton 2015 7 Planned burn 78 No smoke
Warburton 2016 55 Planned burn
Total 183 170
2.1. Participants
Communities likely to be impacted by smoke from planned burns were identified in
conjunction with the Victorian Department of Environment, Land, Water and Planning
(DELWP), the agency responsible for conducting planned burns. Three towns were identi-
fied as suitable study locations in Victoria: Warburton, Traralgon and Maffra/Heyfield [17]
(Figure 1). Residents aged 18 and over were recruited through random digit dialing to
identify interested individuals, with follow-up telephone calls, community advertising and
letter box drops of study information. The aim was for half the sample to be over 65 years
of age, as older age is a risk factor for adverse health outcomes from air pollution. There
were no exclusion criteria based on current health or medical conditions.
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Figure 1. Study locations: Victoria, Australia. 
2.2. Study Period 
The study was conducted from Autumn 2013 to Autumn 2016. 
2.3. Health Assessments 
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event. Clinical tests included: 
• Blood tests, for markers of inflammation and coagulation, specifically high sensitivity 
C-reactive protein (CRP), fibrinogen, and a full blood examination (including hemo-
globin, total and differential white cell and platelet counts) [17]. 
• Airway inflammation test, measuring fractional exhaled nitric oxide (FeNO) using a 
NiOx unit (Aerocrine AB, Solna, Sweden) [18]. 
2.4. Exposure Assessment 
At a central location in each of the three study areas, an E-sampler aerosol monitor 
(Met One Instruments Inc., Grants Pass, OR, USA) was set up. The E-sampler measured 
continuous PM2.5 concentrations by light scattering, and collected gravimetric measure-
ments on filters, which were used to determine a calibration factor. 
2.5. Statistical Analysis 
Comparisons between men and women were made with Pearson χ2 or Fisher’s exact 
tests. Generalized estimating equations (GEE) were fitted to assess the relationships be-
tween the biomarkers and PM2.5 [19,20]. The GEE calculated the average change in clinical 
measures for each 10 µg/m3 increase in PM2.5 with 95% confidence intervals (this was a 
realistic increase). Data were analyzed using Stata statistical software (Version 12.1, 
StataCorp, College Station, TX, USA). 
Markers of lung and systemic inflammation (FeNO, total white cell (WCC), neutro-
phil, basophil counts, and high sensitivity C-reactive protein (CRP)) were the continuous 
outcomes (dependent variables). The exposure variables were hourly averaged PM2.5 con-
centrations. Analyses were performed for the following lag periods: 4 h (PM2.5 concentra-
tion in the 4 h prior to the test), 8 h, 12 h, 24 h and 48 h. 
The parameter estimates from the GEE models may be interpreted as proportional 
changes in the levels of individual biomarkers. We calculated the changes in biomarker 
levels associated with exposure per 10 µg/m3 PM2.5 from outdoor smoke. 
All analyses controlled for known confounders of temperature and humidity. Sec-
ondary analyses also controlled for individual smoking status, age and history of asthma. 
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2.2. Study Period
The study was conducted from Autumn 2013 to Autumn 2016.
2.3. Health Assessments
Participants attended two appointments for clinical testing, one during a period with
no known source of outdoor smoke (the clean air assessment) and one during a smoke
event. Clinical tests included:
• Blood tests, for markers of inflammation and coagulation, specifically high sensi-
tivity C-reactive protein (CRP), fibrinogen, and a full blood examination (including
hemoglobin, total and differential white cell and platelet counts) [17].
• Airway inflammation test, measuring fractional exhaled nitric oxide (FeNO) using a
NiOx unit (Aerocrine AB, Solna, Sweden) [18].
2.4. Exposure Assessment
At a central location in each of the three study areas, an E-sampler aerosol monitor
(Met One Instruments Inc., Grants Pass, OR, USA) was set up. The E-sampler measured con-
tinuous PM2.5 concentrations by light scattering, and collected gravimetric measurements
on filters, which were used to determine a calibration factor.
2.5. Statistical Analysis
Comparisons between men and women were made with Pearson χ2 or Fisher’s exact
tests. Generalized es imating equations (GEE) were fitted to assess the relation hips
b tween the biomarkers and PM2.5 [19,20]. The GEE calculated the average change in
clinical m asures for each 10 µg/m3 increas in PM2.5 with 95% confidence i tervals (this
was a realistic increase). Data were analyzed using Stata statistical software (Version 12.1,
StataCorp, College Station, TX, USA).
Markers of lung and systemic inflammation (FeNO, total white cell (WCC), neutrophil,
basophil counts, and high sensitivity C-reactive protein (CRP)) ere the continuous out-
comes (dependent variables). The exposure variables were hourly averaged PM2.5 concen-
trations. Analyses were performed for the following lag periods: 4 h (PM2.5 concentration
in the 4 h prior to the test), 8 h, 12 h, 24 h and 48 h.
The parameter estimates from the GEE models may be interpreted as proportional
changes in the levels of individual biomarkers. We calculated the changes in biomarker
levels associated with exposure per 10 µg/m3 PM2.5 from outdoor smoke.
All analyses controlled for known confounders of temperature and humidity. Sec-
ondary analyses also controlled for individual smoking status, age and history of asthma.
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All analyses were conducted using Stata (version 14.1; StataCorp, College Station, TX,
USA). p-values < 0.05 were considered statistically significant [21].
2.6. Ethics Approval
This study was approved by the Monash University Human Research Ethics Commit-
tee CF12/3097-2012001570 and the Human Research Ethics Committee of the University
of Tasmania, reference number H0013022. All participants provided written, informed
consent.
3. Results
There was a total of 207 participants enrolled in the full study with a subset of 183 who
completed repeat measurements included in these analyses (Supplementary File S1). The
participants’ mean age (SD, min and max) was 63.5 (12.2, 26 and 92) years and 60% were
female (Table 2). Just under half (46%) of the participants were aged over 65 years. A
similar proportion had ever smoked tobacco for at least one year. Inhabitants had lived
in the study region for a median of 22 (IQR 10 to 38 years) and the majority (69%) were
from Warburton. Common co-morbidities included asthma, COPD, ischemic heart disease,
heart failure and diabetes. The men were significantly older than the women, less likely to
be current smokers and more likely to have heart failure or other heart conditions.
Table 2. Demographics and clinical characteristics of study participants.
Characteristic Women Total(n = 110) Proportions
Men Total
(n = 73) Proportions p-Value
Age > 65 years 40 36.0% 44 60.3% 0.001
Current regular smoker 15 13.6% 3 4.1% 0.034
Smoked at all last month 33 30.0% 20 27.4% 0.75
Ever smoked 41 37.2% 32 43.8% 0.72
Asthma diagnosed 17 15.5% 12 16.4% 0.86
Asthma attack in the last 12 months 6 5.5% 0 0% 0.028 *
Asthma medication 10 9.1% 8 11.0% 0.97
COPD 4 3.6% 4 5.6% 0.80
Other respiratory condition 6 5.5% 5 6.8% 0.94
Hypertension 41 37.3% 28 38.4% 0.88
Angina 4 3.6% 7 9.6% 0.18
High Cholesterol 31 28.2% 21 28.8% 0.93
Myocardial infarction or coronary event 5 4.5% 9.6% 0.23 *
Heart Failure 1 0.9% 5 6.8% 0.039 *
Arrhythmia 14 12.7% 10 13.7% 0.85
Stroke or TIA 2 1.8% 5 6.8% 0.12 *
Other heart condition 3 2.7% 8 11.0% 0.028 *
Diabetes 14 12.7% 9 12.3% 0.94
Self-reported cold or flu symptoms 18 16.5% 10 13.7% 0.61
Immune modulators 3 2.7% 0 0.0% -
Non-Steroidal anti-inflammatories 2 1.8% 1 1.4% -
Anti-platelet medication 8 7.2% 8 10.9% -
Asthma Inhalers/preventers 10 9.1% 8 10.9% -
Antihistamines 2 1.8% 0 0.0% -
* Fisher’s exact test.
There was significant variation in the exposure to PM2.5 from the different smoke
sources. Planned burns and wildfire smoke were only recorded in Warburton (Figures 2
and 3) due to limited burning seasons across the 4-year study period. No smoke from any
source was detected in Maffra/Heyfield during the study period, as scheduled planned
burns did not proceed during this time due to local weather conditions. In 2014, there was
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a coal mine fire near Traralgon, and the air quality in Traralgon was impacted by the smoke
from these fires during our study (Figure 4).




Figure 2. Average 24 h concentrations of PM2.5 (µg/m3) measured in Warburton between March 1 
and 30 April 2016. Health assessments were conducted on 1 April 2016 and 19–21 April 2016. Note 
that planned burns were conducted near Warburton during the study. 
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Figure 3. Boxplots showing median, quartiles and extreme concentrations of PM2.5 (µg/m3) as
mea ured n the day’s health assessments were conducted in Warburton in 2014. Note that wildfires
only occurred near Warburton during this study period.




Figure 4. Boxplots showing median, quartiles and extreme concentrations of PM2.5 (µg/m3) as 
measured on the day’s health assessments were conducted in Traralgon. Note that the coal mine 
fire only impacted Traralgon during the study. 
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48-h lag periods associated with PM2.5 exposures from outdoor smoke events (Table 4). 
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ysis for the different sources of the smoke (coal mine fire, planned burn and forest fire 
smoke) showed positive associations between FeNO and exposure to coal mine fire smoke 
for the 4-h lag period (Table 3). 
Table 3. Changes in fractional exhaled nitric oxide (FeNO) (ppb) Regression coefficients (β) and 
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Coal Mine Fire Smoke 12 0.196 (−1.467 to 1.859) 0.817 
All 24 0.381 (−0.036 to 0.798) 0.073 
Planned Burns Smoke 24 0.497 (−0.050 to 1.044) 0.075 
Wildfire Smoke 24 1.073 (0.846 to 1.299) <0.001 
Coal Mine Fire Smoke 24 0.538 (−1.431 to 2.506) 0.593 
All 48 0.344 (−0.154 to 0.842) 0.176 
Planned Burns Smoke 48 0.761 (−0.165 to 1.686) 0.107 
Wildfire Smoke 48 0.789 (0.539 to 1.040) <0.001 
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Table 4. Changes in total white cell count (WCC) and neutrophil counts Regression coefficients (β)
and 95% confidence intervals per 10 µg/m3 PM2.5 adjusted for temperature, humidity, smoking
status, asthma diagnosis and age.
Exposure Type Outcome Exposure Period(h) β 95% CI p
All WCC 24 −0.088 (−0.171 to −0.006) 0.036
Planned Burns WCC 24 −0.069 (−0.178 to 0.041) 0.218
Wildfire Smoke WCC 24 −0.108 (−0.235 to 0.018) 0.094
Coal Mine Fire WCC 24 −0.203 (−0.605 to 0.200) 0.324
All WCC 48 −0.092 (−0.192 to 0.007) 0.070
All Neutrophils 24 −0.077 (−0.144 to −0.010) 0.024
Planned Burns Neutrophils 24 −0.065 (−0.156 to 0.026) 0.162
Wildfire Smoke Neutrophils 24 −0.083 (−0.185 to 0.019) 0.112
Coal Mine Fire Neutrophils 24 −0.147 (−0.469 to 0.175) 0.370
All Neutrophils 48 −0.081 (−0.162 to −0.001) 0.048
4. Discussion
This panel study showed that outdoor smoke (smoke from planned burns, wildfires
and a coal mine fire) had an impact on biomarkers, including total white cell and neutrophil
counts, as well as increasing the fractional exhaled nitric oxide consistent with systemic
and airway inflammation.
The results for FeNO were consistent with previous studies, indicating that PM2.5 was
associated with eosinophilic airway inflammation [22–25]. Our results confirmed these
findings, showing positive associations between PM2.5 from outdoor smoke and FeNO.
There was less consistency between the results for the blood markers in our study
and other studies. Previous studies found increases in CRP [26] and fibrinogen associated
with PM2.5 from urban background air pollution, including traffic and woodsmoke [27–31].
It has also been shown in response to transient exposure to PM2.5 from biomass smoke
exposure [32,33] in Finland and North America. This may indicate different components
of these particulate fractions from alternative sources may produce different biological
responses, differences in exposure profiles, or it may indicate that smoke from wildfires
produces different changes in biomarkers depending on the type of vegetation that burns.
Equally, different responses of biomarkers to PM2.5 exposure could be related to duration
of exposure or lack of statistical power.
Mean levels of urban background PM2.5 observed by Huttenen et al. [32] were lower
(8.7 µg/m3) than in our study, however blood samples were taken bi-weekly, which may
have increased sensitivity to changes in biomarkers. Adetona et al. observed PM2.5 TWA
levels of 338 µg/m3 and 240 µg/m3 in their exposed sample of firefighters, with samples
being taken immediately following shifts [33]. There were cross-shift increases in IL8, CRP,
serum amyloid A and segmented neutrophils in peripheral blood.
As Huttunen et al. [32] conducted their study in patients with heart disease, the effect
of biomass smoke may have been more pronounced than in our sample. However, our
panel was composed mainly of elderly individuals, with a high prevalence of heart disease.
Equally, Adetona et al. [33] may have detected an increase in CRP due to the fire fighters’
close proximity to the smoke source and the very high levels of exposure. However, the
strength of this interaction could also have been mitigated by a healthy worker effect.
Finally, increased CRP may be a sign of other inflammatory responses not related to smoke,
perhaps masking any true effects.
Previously, total WCC has been found to be associated with urban background
PM10 [34]. This may be due to different cellular responses to larger particulate fractions, or
from differences in particle composition. Ghio et al. [35] demonstrated increased levels of
neutrophils in bronchial and bronchoalveolar lavage sampled in participants exposed to
PM2.5 from wood smoke. Decreases in neutrophils and total WCC count may indicate cells
moving out of the peripheral blood and into the lungs in response to inflammation. This
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could be investigated further through bronchoalveolar lavage or analysis of exhaled breath
for neutrophil markers.
These results highlight the potential sub-clinical changes resulting from outdoor
smoke exposures. Previous work relating to landscape fires has mainly measured clinical
outcomes such as cardiac arrests and asthma attacks. Our findings suggest that individuals
with asthma should try to reduce their exposure to smoke during wildfires or planned
burns [36]. Importantly, this study also provides a crucial insight into the sub-clinical
changes which may occur in the lead up to an individual suffering an overt adverse health
effect. Further research is needed to determine if this finding is repeated under similar
conditions.
Strengths and Limitations
This study used the paired data from individuals to provide an objective measurement
of the impact of PM2.5 on selected biomarkers. By measuring biomarkers, we were able to
demonstrate objective changes in inflammation and clinically relevant endpoints. As these
measurements were sub-clinical, our study provided an important indication of subtle
health changes during smoke-related PM2.5 exposure.
The main limitation of this study was the difficulty in obtaining a consistent exposure
to smoke due to meteorological variation. Changes in local weather conditions often
resulted in planned burns not occurring, or the smoke not impacting the town. This may
have reduced the chance of finding a potential association between smoke from planned
burns and changes in biomarkers. On the days when planned burns were occurring nearby,
there were frequently negligible amounts of smoke present in the study area. This was likely
due to burn protocols designed to reduce the impact of smoke on communities as much
as is practicable. Equally, the changes only demonstrated correlation and not necessarily
causation. As the panel study relied on repeated measures of returning participants,
there may be a healthy volunteer bias. Another limitation was the time between paired
measurements. Due to changes in the planned burn schedule, there were gaps between
the initial ‘clean’ measurement and the “smoke” measurement of several weeks or months.
Although we have demonstrated similar responses to different sources of smoke, we accept
that the findings should be generalized to other settings with caution.
However, this study has identified health impacts of planned burn smoke on FeNO
and white cell counts. Further research should focus on the potential impact of smoke-
related PM2.5 on vulnerable populations, particularly individuals with pre-existing cardio-
vascular and respiratory conditions. In order to determine if the reduction in WCC and
neutrophils numbers is due to these cells migrating from the peripheral blood to the lungs,
future studies are recommended of these effects on more highly exposed populations, such
as firefighters working on wild fires or planned burns.
5. Conclusions
Outdoor smoke from wildfires, planned burns and a coal mine fire were associated
with increased levels of FeNO, but decreased neutrophils and total WCC in peripheral
blood. This suggests that PM2.5 may cause increased airway inflammation. This may have
significant clinical implications for individuals with pre-existing respiratory conditions or
compromised immune systems. However, there was no evidence of systemic inflammation.
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